Study of the Safety and Effectiveness of Motiva Implants® (NCT03579901) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Study of the Safety and Effectiveness of Motiva Implants®
United States, Germany, Sweden800 participantsStarted 2018-04-06
Plain-language summary
This study evaluates the safety and effectiveness Motiva Implants® in women who are undergoing primary breast augmentation, primary breast reconstruction or revision breast surgery.
Who can participate
Age range
18 Years – 70 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria
* Genetic female.
* Patient is seeking one of the following procedures:
Primary Breast Augmentation Primary Breast Reconstruction Revision Augmentation Revision Reconstruction
* Patient has adequate tissue available to cover implant(s).
* Willingness to follow all study requirements including agreeing to attend all required follow-up visits and signs the informed consent.
* Agrees to have device returned to Establishment Labs if explanted.
* Willing to undergo Magnetic Resonance Imaging (MRI) evaluation of medically advised.
Exclusion Criteria:
* Has any breast disease considered to be pre-malignant in one or both breasts or is reporting mutations in BRCA1 or BRCA2 without a previous bilateral mastectomy or an untreated cancer of any type.
* Has inadequate or unsuitable tissue (e.g., due to radiation damage, ulceration compromised vascularity, history of compromised wound healing).
* Has an abscess or infection.
* Is pregnant or nursing or has had a full-term pregnancy or lactated within 6 months of enrollment.
* Is taking any drugs that would interfere with blood clotting, or that might result in elevated risk and or significant postoperative complications.
* Has any medical condition such as obesity (BMI ≥ 40), diabetes, autoimmune disease, chronic lung or severe cardiovascular disease that might result in unduly high surgical risk and or significant postoperative complications.
* Has any connective tissue/autoimmune disorder or rheumatoid disease, s…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Analyze and report the total adverse events rate ("any complication)" of the Silicone Gel filled Motiva Implants®. Kaplan-Meier analysis of adverse events will be conducted by time period for each type of adverse event.
Timeframe: 10 Years
2
Analyze patient satisfaction on a 5-point Likert scale post-implant for all implantation groups.